Covid Is Making Many Offices Obsolete. Here’s What Happens to Them Next.

Norge Nyheter Nyheter

Covid Is Making Many Offices Obsolete. Here’s What Happens to Them Next.
Norge Siste Nytt,Norge Overskrifter
  • 📰 WSJ
  • ⏱ Reading Time:
  • 13 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 9%
  • Publisher: 63%

In New York and San Francisco, more than 80% of all office space is more than 30 years old. What will become of those buildings now that demand for them has faded?

Allstate Corp.’s suburban campus outside Chicago, with its interconnected buildings, manicured grounds and acres of parking, represented a new vision for the U.S. office when it opened in 1967. That vision is now dead.

The insurer reached a deal last month to sell most of the campus. The new owner plans to demolish the office buildings and convert the Northbrook, Ill., site into more than 3 million square feet of e-commerce warehouses and other logistics facilities.

Vi har oppsummert denne nyheten slik at du kan lese den raskt. Er du interessert i nyhetene kan du lese hele teksten her. Les mer:

WSJ /  🏆 98. in US

Norge Siste Nytt, Norge Overskrifter

Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.

Making New Year's resolutions during Covid has paid off: Fidelity surveyMaking New Year's resolutions during Covid has paid off: Fidelity surveyPeople who made financial resolutions at the start of 2021 are more optimistic about the future and their finances, and the pandemic plays into it.
Les mer »

US expands Pfizer COVID boosters, opens extra dose to age 16US expands Pfizer COVID boosters, opens extra dose to age 16U.S. health authorities again expanded the nation's booster campaign Thursday, opening extra doses of Pfizer’s COVID-19 vaccine to several million 16- and 17-year-olds. The U.S. and many other nations already were urging adults to get booster shots to pump up immunity that can wane months after vaccination, calls that intensified with the discovery of the worrisome new omicron variant. On Thursday, the Food and Drug Administration gave emergency authorization for 16- and 17-year-olds to get a third dose of the vaccine made by Pfizer and its partner BioNTech — once they're six months past their last dose.
Les mer »

'I was symptomatic': Apple employees say store's Covid outbreak goes beyond managers'I was symptomatic': Apple employees say store's Covid outbreak goes beyond managersAn Apple store in Southlake, Texas, is closed Wednesday through Sunday this week following an outbreak of positive Covid-19 cases among staff members.
Les mer »

New York City business owners feeling added stress of COVID vaccine mandate for employeesNew York City business owners feeling added stress of COVID vaccine mandate for employeesEmployees of around 184,000 businesses in the city will have to be at least partially vaccinated by December 27.
Les mer »

HHS Secretary Xavier Becerra: 16-17 Year Olds Are Now Eligible for COVID-19 Booster ShotsHHS Secretary Xavier Becerra: 16-17 Year Olds Are Now Eligible for COVID-19 Booster Shots.CDCgov now recommends that 16 and 17 year-olds get boosters if eligible after at least 6 months of completed Pfizer vaccination. Statement from HHS Secretary Xavier Becerra:
Les mer »

FDA Greenlights Booster Shots Of Pfizer/BioNTech’s Covid Vaccine For 16 And 17-Year-OldsFDA Greenlights Booster Shots Of Pfizer/BioNTech’s Covid Vaccine For 16 And 17-Year-OldsPfizer and BioNTech will also apply to the FDA to expand the approval of their companies' vaccine to include the third dose.
Les mer »



Render Time: 2025-04-21 10:04:27